The G-CSF/G-CSFR signalling axis has been implicated in stimulating neoangiogenesis, tumour cell proliferation, enhanced migratory and metastatic potential, and expansion of the cancer stem cell pool in preclinical models of several solid organ malignancies [51]. The gene discussed is CSF3; the disease is neoplasm.